Y-Intercept (HK)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.76M	Buy	+11,361	New	+$3.87M	0.07%	437
2025 Q4	–	Sell	-2,614	Closed	-$1.19M	–	1506
2025 Q3	$1.19M	Buy	+2,614	New	+$1.06M	0.03%	892
2025 Q2	–	Sell	-3,720	Closed	-$1M	–	1610
2025 Q1	$1M	Sell	3,720 -796	-18%	-$205K	0.07%	404
2024 Q4	$1.06M	Buy	+4,516	New	+$1.19M	0.07%	403
2024 Q3	–	Sell	-46,388	Closed	-$11.3M	–	1269
2024 Q2	$11.3M	Buy	46,388 +43,545	+1,532%	+$6.87M	0.62%	11
2024 Q1	$425K	Buy	2,843 +988	+53%	+$165K	0.03%	796
2023 Q4	$355K	Buy	+1,855	New	+$316K	0.03%	757
2022 Q4	–	Sell	-5,935	Closed	-$1.19M	–	972
2022 Q3	$1.19M	Buy	+5,935	New	+$1.13M	0.12%	267
2022 Q1	–	Sell	-3,134	Closed	-$531K	–	706
2021 Q4	$531K	Buy	+3,134	New	+$582K	0.13%	235
2021 Q3	–	Sell	-7,592	Closed	-$1.29M	–	629
2021 Q2	$1.29M	Buy	7,592 +3,832	+102%	+$561K	0.33%	59
2021 Q1	$508K	Buy	+3,760	New	+$566K	0.14%	254